Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STANCE: a unified statistical model to detect cell-type-specific spatially variable genes in spatial transcriptomics. | Nat Commun | 2025 | 39979358 | PubTator, text mining | PubMed |
| IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality. | Oncoimmunology | 2025 | 39960378 | PubTator, text mining | PubMed |
| Plant-derived Pembrolizumab in conjugation with IL-15Rα-IL-15 complex shows effective anti-tumor activity. | PLoS One | 2025 | 39808627 | PubTator, text mining | PubMed |
| Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis. | Allergy | 2025 | 39760239 | PubTator, text mining | PubMed |
| Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications. | Diabetes Obes Metab | 2025 | 39562286 | PubTator, text mining | PubMed |
| Mendelian randomization supports causal effects of inflammatory biomarkers on myopic refractive errors. | Eur J Ophthalmol | 2025 | 39094556 | PubTator, text mining | PubMed |
| IL-15/IL-15Ra Synergies with IL-12 to Induce Functional CD8 T Cells and NK Cells During Chronic SHIV Infection. | AIDS Res Hum Retroviruses | 2025 | 39041621 | PubTator, text mining | PubMed |
| Current status and research progress of oncolytic virus. | Pharm Sci Adv | 2024 | 41550155 | PubTator, text mining | PubMed |
| Interleukin 15: A new intermediary in the effects of exercise and training on skeletal muscle and bone function. | J Cell Mol Med | 2024 | 39601091 | PubTator, text mining | PubMed |
| Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study. | J Ovarian Res | 2024 | 39501339 | PubTator, text mining | PubMed |
| A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responses. | Mol Ther | 2024 | 39489922 | PubTator, text mining | PubMed |
| Exploring the Blood Biomarkers and Potential Therapeutic Agents for Human Acute Mountain Sickness Based on Transcriptomic Analysis, Inflammatory Infiltrates and Molecular Docking. | Int J Mol Sci | 2024 | 39457093 | PubTator, text mining | PubMed |
| Causal relationship between circulating inflammatory proteins and risk of different types of encephalitis: A two-sample Mendelian randomization study. | Cytokine | 2024 | 39447339 | PubTator, text mining | PubMed |
| Correction: The JAK-STAT pathway: from structural biology to cytokine engineering. | Signal Transduct Target Ther | 2024 | 39419998 | PubTator, text mining | PubMed |
| IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39396119 | PubTator, text mining | PubMed |
| Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer. | Sci Rep | 2024 | 39389985 | PubTator, text mining | PubMed |
| Identification of novel proteins for coronary artery disease by integrating GWAS data and human plasma proteomes. | Heliyon | 2024 | 39386869 | PubTator, text mining | PubMed |
| IL-1β Induces Human Endothelial Surface Expression of IL-15 by Relieving let-7c-3p Suppression of Protein Translation. | J Immunol | 2024 | 39302113 | PubTator, text mining | PubMed |
| Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics. | Chin Med | 2024 | 39289763 | PubTator, text mining | PubMed |
| Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder. | Exp Hematol Oncol | 2024 | 39267145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=6